{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:54:35Z","timestamp":1791179675680,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.vaccine.2013.11.071","type":"journal-article","created":{"date-parts":[[2013,12,2]],"date-time":"2013-12-02T02:15:14Z","timestamp":1385950514000},"page":"311-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Novel vaccination approaches against equine alphavirus encephalitides"],"prefix":"10.1016","volume":"32","author":[{"given":"Mariano","family":"Carossino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Thiry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"de la Grandi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Barrandeguy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.11.071_bib0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1756-3305-3-35","article-title":"Emergence of zoonotic arboviruses by animal trade and migration","volume":"3","author":"Pfeffer","year":"2010","journal-title":"Parasites & Vectors"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0010","doi-asserted-by":"crossref","first-page":"e1875","DOI":"10.1371\/journal.pntd.0001875","article-title":"Venezuelan equine encephalitis virus activity in the Gulf Coast region of Mexico, 2003\u20132010","volume":"6","author":"Adams","year":"2012","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0015","series-title":"Infectious diseases of the horse","first-page":"95","article-title":"Alphaviral encephalomyelitis (EEE, WEE and VEE)","author":"MacKay","year":"2009"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0020","series-title":"Manual of diagnostic tests and vaccines for terrestrial animals","first-page":"852","article-title":"Equine encephalomyelitis (Eastern and Western)","author":"[OIE] WOfAH","year":"2012"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0025","series-title":"Manual for diagnostic tests and vaccines for terrestrial animals","first-page":"924","article-title":"Venezuelan equine encephalomyelitis","author":"[OIE] WOfAH","year":"2012"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0030","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.vaccine.2011.12.121","article-title":"A vaccine candidate for eastern equine encephalitis virus based on IRES-mediated attenuation","volume":"30","author":"Pandya","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0035","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.vaccine.2013.01.014","article-title":"A chimeric Sindbis-based vaccine protects cynomolgus macaques against a lethal aerosol challenge of eastern equine encephalitis virus","volume":"31","author":"Roy","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0040","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1016\/j.vaccine.2007.05.054","article-title":"Single-dose, fast-acting vaccine candidate against western equine encephalitis virus completely protects mice from intranasal challenge with different strains of the virus","volume":"25","author":"Barabe","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0045","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1016\/j.vaccine.2009.05.011","article-title":"Chimeric alphavirus vaccine candidates protect mice from intranasal challenge with western equine encephalitis virus","volume":"27","author":"Atasheva","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0050","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1743-422X-6-118","article-title":"Improved efficacy of a gene optimised adenovirus-based vaccine for Venezuelan equine encephalitis virus","volume":"6","author":"Williams","year":"2009","journal-title":"Virology Journal"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0055","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.vaccine.2012.12.050","article-title":"Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine","volume":"31","author":"Tretyakova","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0060","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1016\/j.vaccine.2006.02.020","article-title":"Boosting with an adenovirus-based vaccine improves protective efficacy against Venezuelan equine encephalitis virus following DNA vaccination","volume":"24","author":"Perkins","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0065","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1051\/vetres:2004019","article-title":"Equine viral vaccines: the past, present and future","volume":"35","author":"Minke","year":"2004","journal-title":"Veterinary Research"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0070","series-title":"Equine internal medicine","first-page":"624","article-title":"Viral encephalitis","author":"Bertone","year":"2010"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/tvjl.1998.0289","article-title":"Molecular epidemiological studies of veterinary arboviral encephalitides","volume":"157","author":"Weaver","year":"1999","journal-title":"Veterinary Journal"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2013.07.012","article-title":"Pathogenesis of Venezuelan equine encephalitis","author":"Taylor","year":"2013","journal-title":"Veterinary Microbiology"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0085","series-title":"Eastern equine encephalomyelitis, Western equine encephalomyelitis and Venezuelan equine encephalomyelitis","first-page":"1","author":"CfFSaPH","year":"2008"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0090","series-title":"Togaviridae","first-page":"456","article-title":"Fenner\u2019 veterinary virology","author":"MacLachlan","year":"2010"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0095","series-title":"Equine infectious diseases","first-page":"191","article-title":"Equine alphaviruses","author":"Gibbs","year":"2007"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0100","series-title":"Alphavirus encephalitides","first-page":"241","author":"Steele","year":"2008"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0105","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.vetmic.2009.08.023","article-title":"Encephalitic alphaviruses","volume":"140","author":"Zacks","year":"2010","journal-title":"Veterinary Microbiology"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0110","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.ento.49.061802.123422","article-title":"Venezuelan equine encephalitis","volume":"49","author":"Weaver","year":"2004","journal-title":"Annual Review of Entomology"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0115","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.1128\/JVI.79.17.11300-11310.2005","article-title":"Variation in interferon sensitivity and induction among strains of eastern equine encephalitis virus","volume":"79","author":"Aguilar","year":"2005","journal-title":"Journal of Virology"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0120","doi-asserted-by":"crossref","first-page":"7573","DOI":"10.1016\/j.vaccine.2007.07.061","article-title":"Chimeric Sindbis\/eastern equine encephalitis vaccine candidates are highly attenuated and immunogenic in mice","volume":"25","author":"Wang","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0125","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1099\/vir.0.008656-0","article-title":"Virulence variation among isolates of western equine encephalitis virus in an outbred mouse model","volume":"90","author":"Logue","year":"2009","journal-title":"The Journal of General Virology"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0130","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.vaccine.2004.06.056","article-title":"Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus","volume":"23","author":"Phillpotts","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0135","doi-asserted-by":"crossref","first-page":"630","DOI":"10.4269\/ajtmh.1999.60.630","article-title":"Geographic distribution of Venezuelan equine encephalitis virus subtype IE genotypes in Central America and Mexico","volume":"60","author":"Oberste","year":"1999","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0140","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.vaccine.2006.10.030","article-title":"Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses","volume":"25","author":"Fine","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0145","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0264-410X(98)00335-1","article-title":"Expression, processing, and immunogenicity of the structural proteins of Venezuelan equine encephalitis virus from recombinant baculovirus vectors","volume":"17","author":"Hodgson","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0150","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1038\/emboj.2011.261","article-title":"4.4A\u00b0 cryo-EM structure of an enveloped alphavirus Venezuelan equine encephalitis virus","volume":"30","author":"Zhang","year":"2011","journal-title":"EMBO Journal"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0155","series-title":"Field virology","first-page":"1023","article-title":"Alphaviruses","author":"Griffin","year":"2007"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0160","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1128\/CVI.00377-09","article-title":"Identification of Western equine encephalitis virus structural proteins that confer protection after DNA vaccination","volume":"17","author":"Gauci","year":"2010","journal-title":"Clinical and Vaccine Immunology: CVI"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0165","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1099\/0022-1317-81-1-151","article-title":"Complete genomic RNA sequence of western equine encephalitis virus and expression of the structural genes","volume":"81","author":"Netolitzky","year":"2000","journal-title":"The Journal of General Virology"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0170","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0166-3542(04)00126-3","article-title":"Evaluation of a Western Equine Encephalitis recombinant E1 protein for protective immunity and diagnostics","volume":"64","author":"Das","year":"2004","journal-title":"Antiviral Research"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0175","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.virusres.2007.03.030","article-title":"Immunological evaluation of Escherichia coli expressed E2 protein of Western equine encephalitis virus","volume":"128","author":"Das","year":"2007","journal-title":"Virus Research"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0180","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.vetmic.2007.10.022","article-title":"Cloning, expression and purification of envelope proteins E1 and E2 of western equine encephalitis virus and potential use of them as antigens in immunoassays","volume":"128","author":"Hu","year":"2008","journal-title":"Veterinary Microbiology"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0185","series-title":"Equine infectious diseases","first-page":"556","article-title":"Immunoprophylaxis","author":"Wilson","year":"2007"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0190","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1016\/S0264-410X(03)00328-1","article-title":"Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models","volume":"21","author":"Pratt","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0195","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.virol.2012.11.013","article-title":"IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice","volume":"437","author":"Rossi","year":"2013","journal-title":"Virology"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2013.11.071_bib0200","doi-asserted-by":"crossref","first-page":"D80","DOI":"10.1016\/j.vaccine.2009.07.095","article-title":"Vaccines for Venezuelan equine encephalitis","volume":"27","author":"Paessler","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0205","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1016\/j.vaccine.2009.04.049","article-title":"Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine","volume":"27","author":"Dupuy","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0210","doi-asserted-by":"crossref","first-page":"9278","DOI":"10.1128\/JVI.77.17.9278-9286.2003","article-title":"Recombinant sindbis\/Venezuelan equine encephalitis virus is highly attenuated and immunogenic","volume":"77","author":"Paessler","year":"2003","journal-title":"Journal of Virology"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0215","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.pep.2011.08.002","article-title":"Factors affecting recombinant Western equine encephalitis virus glycoprotein production in the baculovirus system","volume":"80","author":"Toth","year":"2011","journal-title":"Protein Expression and Purification"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0220","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/viro.2002.1677","article-title":"Recombinant chimeric western and eastern equine encephalitis viruses as potential vaccine candidates","volume":"302","author":"Schoepp","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0225","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/viro.1995.1458","article-title":"Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1","volume":"212","author":"Davis","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0230","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0264-410X(01)00337-1","article-title":"Onset and duration of protective immunity to IA\/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated mice","volume":"20","author":"Hart","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0235","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1016\/j.vaccine.2004.12.023","article-title":"Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus","volume":"23","author":"Reed","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0240","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.4269\/ajtmh.1999.60.1041","article-title":"Limited potential for mosquito transmission of genetically engineered, live-attenuated Venezuelan equine encephalitis virus vaccine candidates","volume":"60","author":"Turell","year":"1999","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0245","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.vaccine.2005.01.032","article-title":"Efficacy of DNA vaccination against western equine encephalitis virus infection","volume":"23","author":"Nagata","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0250","doi-asserted-by":"crossref","first-page":"13552","DOI":"10.1128\/JVI.01576-07","article-title":"Analysis of Venezuelan equine encephalitis virus capsid protein function in the inhibition of cellular transcription","volume":"81","author":"Garmashova","year":"2007","journal-title":"Journal of Virology"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0255","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1128\/JVI.02075-06","article-title":"Capsid protein of eastern equine encephalitis virus inhibits host cell gene expression","volume":"81","author":"Aguilar","year":"2007","journal-title":"Journal of Virology"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0260","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1128\/JVI.02554-09","article-title":"Venezuelan equine Encephalitis virus capsid protein forms a tetrameric complex with CRM1 and importin alpha\/beta that obstructs nuclear pore complex function","volume":"84","author":"Atasheva","year":"2010","journal-title":"Journal of Virology"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0265","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1016\/S0264-410X(03)00362-1","article-title":"Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus","volume":"21","author":"Riemenschneider","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0270","doi-asserted-by":"crossref","first-page":"7345","DOI":"10.1016\/j.vaccine.2010.09.005","article-title":"Immunogenicity and protective efficacy of a DNA vaccine against Venezuelan equine encephalitis virus aerosol challenge in nonhuman primates","volume":"28","author":"Dupuy","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0275","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1128\/CVI.00030-11","article-title":"A DNA vaccine for Venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates","volume":"18","author":"Dupuy","year":"2011","journal-title":"Clinical and Vaccine Immunology: CVI"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0280","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1016\/j.vaccine.2009.04.015","article-title":"CD4+ T cells provide protection against acute lethal encephalitis caused by Venezuelan equine encephalitis virus","volume":"27","author":"Yun","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0285","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ymthe.2004.07.013","article-title":"Adenoviruses as vaccine vectors","volume":"10","author":"Tatsis","year":"2004","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0290","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1016\/j.vaccine.2007.03.042","article-title":"Complete protection of mice against a lethal dose challenge of western equine encephalitis virus after immunization with an adenovirus-vectored vaccine","volume":"25","author":"Wu","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0295","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/297070a0","article-title":"Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis","volume":"297","author":"Schmaljohn","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0300","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1128\/JVI.71.1.613-623.1997","article-title":"Recombinational history and molecular evolution of western equine encephalomyelitis complex alphaviruses","volume":"71","author":"Weaver","year":"1997","journal-title":"Journal of Virology"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0305","doi-asserted-by":"crossref","first-page":"774","DOI":"10.4269\/ajtmh.2007.76.774","article-title":"Recombinant alphaviruses are safe and useful serological diagnostic tools","volume":"76","author":"Ni","year":"2007","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0310","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/erv.11.188","article-title":"Technologies for enhanced efficacy of DNA vaccines","volume":"11","author":"Saade","year":"2012","journal-title":"Expert Review of Vaccines"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0315","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jbiotec.2012.08.012","article-title":"The future of human DNA vaccines","volume":"162","author":"Li","year":"2012","journal-title":"Journal of Biotechnology"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0320","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1128\/JVI.75.9.4040-4047.2001","article-title":"West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays","volume":"75","author":"Davis","year":"2001","journal-title":"Journal of Virology"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0325","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1297-9716-43-16","article-title":"Recent progress in West Nile virus diagnosis and vaccination","volume":"43","author":"De Filette","year":"2012","journal-title":"Veterinary Research"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0330","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0952-7915(00)00118-7","article-title":"DNA vaccines: a key for inducing long-term cellular immunity","volume":"12","author":"Gurunathan","year":"2000","journal-title":"Current Opinion in Immunology"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0335","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1189\/jlb.68.6.793","article-title":"DNA vaccination: antigen presentation and the induction of immunity","volume":"68","author":"Shedlock","year":"2000","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0340","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1146\/annurev.immunol.18.1.927","article-title":"DNA vaccines: immunology, application, and optimization*","volume":"18","author":"Gurunathan","year":"2000","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0345","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1016\/S0264-410X(03)00504-8","article-title":"Rabies DNA vaccine in the horse: strategies to improve serological responses","volume":"21","author":"Fischer","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0350","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.virol.2005.04.014","article-title":"Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine","volume":"337","author":"Pacheco","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0355","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0264-410X(01)00458-3","article-title":"Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD","volume":"20","author":"Gogev","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0360","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.vetimm.2008.02.002","article-title":"A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse","volume":"123","author":"El Garch","year":"2008","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0365","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.vetimm.2009.11.007","article-title":"Onset and duration of immunity to equine influenza virus resulting from canarypox-vectored (ALVAC) vaccination","volume":"135","author":"Soboll","year":"2010","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0370","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1128\/CVI.00249-07","article-title":"Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model","volume":"14","author":"Seino","year":"2007","journal-title":"Clinical and Vaccine Immunology: CVI"},{"key":"10.1016\/j.vaccine.2013.11.071_bib0375","doi-asserted-by":"crossref","first-page":"e70000","DOI":"10.1371\/journal.pone.0070000","article-title":"Identification of hotspots in the European union for the introduction of four zoonotic arboviroses by live animal trade","volume":"8","author":"Durand","year":"2013","journal-title":"PLoS one"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13016332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13016332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T15:37:53Z","timestamp":1688830673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13016332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0264410X13016332"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.071","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel vaccination approaches against equine alphavirus encephalitides","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}